Abstract Background Artificial intelligence (AI) has shown substantial potential in tuberculosis (TB). However, physicians’ distrust of “black-box” algorithms remains a major barrier to clinical adoption. Although explainable AI (XAI) has emerged to enhance transparency, limited evidence exists regarding TB physicians’ specific needs for AI explainability in high-uncertainty infectious disease contexts. Method A qualitative descriptive study was conducted between November 2025 and January 2026 in Hubei Province, China. 26 TB physicians participated in semi-structured interviews. Data were analyzed using an inductive-deductive thematic analysis approach. Coding was conducted independently by two researchers and refined through iterative discussion until thematic saturation was reached. Results Five overarching themes emerged, including global explanations, local explanations, case-based explanations, mixed visual-text presentation formats, and implementation considerations. Physicians emphasized the importance of exclusionary explanations to support differential diagnosis and preferred concise, multimodal outputs aligned with clinical workflows. Optional access to detailed information was favored to reduce cognitive burden. Seamless system integration, institutional financial support, and robust data security were considered essential for AI adoption. Conclusion XAI in TB extends beyond algorithmic transparency and functions as cognitive support for differential reasoning and trust calibration. User-centered, context-sensitive AI explanation design and supportive institutional policies are critical to ensuring responsible and effective integration of AI into infectious disease practice.
The method, ECCOLA, is presented, which aims at making the high-level AI ethics principles more practical, making it possible for developers to more easily implement them in practice.
Ville Vakkuri, Kai-Kristian Kemell, P. Abrahamsson· EUROMICRO Conference on Soft...· 64 citations· ⚡6
The goal is to not only refine the accuracy of the LLM-based tool but also to underscore its potential in streamlining the software development lifecycle through proactive code improvement and education.
Z. Rasheed, Malik Abdul Sami, Muhammad Waseem et al.· arXiv.org· 62 citations· ⚡3
The use of large language models to automatically improve the user story quality in Austrian Post Group IT agile teams is explored, with a reference model for an Autonomous LLM-based Agent System developed and implemented at the company.
Zheying Zhang, M. Rayhan, Tomas Herda et al.· International Conference on...· 48 citations· ⚡4
This paper introduces a novel multi-AI-agent system designed to fully automate SLRs, and demonstrates how it substantially reduces the time and effort traditionally required for SLRs while maintaining comprehensiveness and precision.
Abdul Malik Sami, Z. Rasheed, Kai-Kristian Kemell et al.· arXiv.org· 44 citations· ⚡2
The proposed LLM-based multi-agent system automates qualitative data analysis process, creating opportunities for researchers and practitioners, and future improvements focus on enhancing multilingual performance and integrating continuous expert feedback.
Z. Rasheed, Muhammad Waseem, Aakash Ahmad et al.· arXiv.org· 41 citations
Research Manager Mike Walker reflects on a career spanning hacker culture, cybersecurity, and AI, sharing lessons about trust, teamwork, leadership, and why solving difficult problems requires curiosity, judgment, agility—and an understanding of the rules. The post Learn the rules: The hacker mindset appeared first on Microsoft Research.
Is your company’s AI sovereign? A practical guide for CIOs on AI vendor lock-in, EU Data Act switching, cloud sovereignty, and testing your exit plan before you need it. The post Sovereignty Is the Option to Leave appeared first on GPT-Lab.
MIT News · Artificial Intelligence· news.mit.eduNov 2, 2026
The MIT professors collaborated to identify the first AI-discovered antibiotic, a scientific breakthrough that is widely recognized as a milestone in AI-driven drug discovery.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.